Twitxy Saved

Valentine C. Nriagu MD, MPH.

@NriaguVal

PGY-3 IM Resident | Heart & Vascular | Clinical & Outcomes Research.
Joined April 2013
5.6K Following 1.5K Followers 1.4K Posts

Latest posts 5

Valentine C. Nriagu MD, MPH. @NriaguVal
Great study adding to trials like the COMPASS trial and AFIRE trial.

The EPIC-CAD and AFIRE trial only included Asian patients and inter ethnic differences may exist.

Editorial by Gregory Y.H. Lip, M.D gives an insight. nejm.org/doi/full/10.10…
www.nejm.org Atrial Fibrillation and Stable Coronary Artery Disease | NEJM Patients with atrial fibrillation are at high risk for stroke, and international guidelines recommend oral anticoagulant therapy. In patients with stable vascular disease without atrial fibrillatio...
The EPIC-CAD trial showed that edoxaban monotherapy was superior to edoxaban/antiplatelet therapy at preventing major adverse ischemic/bleeding events.

Read the full clinical trial details here: bit.ly/3Xp77WJ #cvCAD
View quoted post on X